Latest News

SOUL: Oral Semaglutide Aids CV Risk in T2D
Written by: Radcliffe CVRM
SOUL: Oral Semaglutide Aids CV Risk in T2D
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Written by: Cardiac Failure Review
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Written by: Interventional Cardiology Review Journal
FFR-Guided NSTEMI Care Fails to Improve Long-Term Outcomes
GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes
Written by: Radcliffe CVRM
GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes
LAAC Not Non-Inferior to Medical Care in High-Risk AF
Written by: Interventional Cardiology Review Journal
LAAC Not Non-Inferior to Medical Care in High-Risk AF
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
Written by: Arrhythmia and Electrophysiology Review
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
TEER Linked to Better Outcomes in AFMR Patients
Written by: Transcatheter Academy
TEER Linked to Better Outcomes in AFMR Patients
DEDICATE: TAVI vs SAVR Outcomes by Sex in Aortic Stenosis
Written by: Transcatheter Academy
DEDICATE: TAVI vs SAVR Outcomes by Sex in Aortic Stenosis
Semaglutide May Aid Vascular Repair in High-Risk Patients
Written by: Radcliffe CVRM
Semaglutide May Aid Vascular Repair in High-Risk Patients
Aldosteronism Linked to AF and Stroke Risk in Older Adults
Written by: Radcliffe CVRM
Aldosteronism Linked to AF and Stroke Risk in Older Adults

External news

Written by: Medscape
Preventive Care With the Most Bang for Your Buck
Written by: Medscape
FDA Seeks Advice on Researching Drug Risks in Pregnancy
Written by: Cardiac Vascular News
RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Written by: Cardiac Vascular News
WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure
Written by: Medscape
May 08 2026 This Week in Cardiology
Written by: Cardiovascular Business
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia
Written by: Cardiovascular Business
FDA announces more recalls due to risk of syringe breaking during treatment
Written by: Cardiovascular Business
How expert guidelines have influenced TAVR vs. SAVR decisions
Written by: Cardiac Vascular News
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
Written by: Medscape
ESOC 2026